• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Seattle Genetics, Inc. (SGEN)

    -NasdaqGS
    26.87 Down 2.17(7.47%) 4:00PM EST
    Prev Close:29.04
    Open:28.25
    Bid:19.10 x 100
    Ask:28.50 x 300
    1y Target Est:48.27
    Beta:2.00616
    Earnings Date:Apr 28 - May 2 (Est.)
    Day's Range:26.02 - 28.39
    52wk Range:26.02 - 52.33
    Volume:3,669,599
    Avg Vol (3m):1,141,220
    Market Cap:3.75B
    P/E (ttm):N/A
    EPS (ttm):-0.98
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGEN

    Comparison

    Symbol% ChgMkt Cap
    SGENDown 7.47%3.75B
    IMGNDown 1.54%611.17M
    PFEUp 1.34%182.06B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.75
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.95
    Quarterly EPS Est (Dec-15) :-0.20
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-1.78

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback